Skip to the page

Data / Form D filings / 4DMedical Ltd

4DMedical Ltd: Form D filing

4DMedical Ltd, a biotechnology company in Carlton, Australia, filed a Form D with the SEC in 2025. The latest, on July 7, 2025, reports $15 million sold of a $15 million offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
Level 7, 700 Swanston Street, Carlton, Australia, VIC 3
Phone
61- 3 9545 5940
Industry
Biotechnology
Entity type
Other (Australian Ltd.)
Incorporated in
Australia
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2075735

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 7, 2025New notice$14,964,623$14,964,6233May 29, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Lillian Christos BianchiDirector
Geraldine Bernadette McGintyDirector
Andreas Christos FourasExecutive Officer, Director
John Andrew LivingstonDirector
Julian Bernard Kingsley SuttonDirector
Robert Alan FiglinDirector

Every Form D from the week of Jul 7, 2025 · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what 4DMedical Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.